ROSG
Rosetta Genomics, Ltd.
NasdaqCM
People also watch:RXIIPSTINSPHCLSNCYCC
1.09-0.02 (-1.80%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close1.11
Open1.12
Bid1.05 x 1500
Ask1.16 x 500
52wk Range0.71 - 3.25
Day's Range1.08 - 1.12
Volume77,089
Avg Vol (3m)313,184
As of 4:00 PM EDT. Market closed.
  • Benzinga12 days ago

    Rosetta Genomics Gets Patent Allowance For microRNA-based Ovarian Cancer Treatment

    Rosetta Genomics Ltd. (NASDAQ: ROSG ) revealed that the Patent and Trademark Office in the United States has issued a notice of allowance for its patent, entitled "Compositions and methods for treatment ...

  • Rosetta Genomics Ltd. :ROSG-US: Earnings Analysis: Q1, 2016 By the Numbers : June 22, 2016
    Capital Cubelast month

    Rosetta Genomics Ltd. :ROSG-US: Earnings Analysis: Q1, 2016 By the Numbers : June 22, 2016

    Click here to see latest analysisRosetta Genomics Ltd. reports financial results for the quarter ended March 31, 2016.We analyze the earnings along side the following peers of Rosetta Genomics Ltd. – Veracyte Inc, Genomic Health, Inc., Foundation Medicine, Inc., Trovagene, Inc., Exact Sciences Corporation, Teva Pharmaceutical Industries Limited Sponsored ADR, Biocept, Inc. and GeneNews Limited […] (Read more...) The post Rosetta Genomics Ltd. :ROSG-US: Earnings Analysis: Q1, 2016 By the Numbers : June 22, 2016 appeared first on CapitalCube.